New ACIP Recommendations for RSV Vaccines Aim to Solve Challenges With Shared Clinical Decision-Making
Shared clinical decision-making presented drawbacks, resulting in age-based recommendations for adults aged 75 years and older and risk-based recommendations for individuals aged 60-74 years.
Study: Higher Risk of Mental Health Conditions Present in Patients With an Aneurysm Diagnosis
Those with an aneurysm diagnosis who were younger than 40 years of age were observed to have an even higher risk.
David S. Taylor, PharmD, 340B ACE
Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.
The Future of the 340B Drug Pricing Program in Modern Health Care
An examination of the 340B Drug Pricing Program's original intent, current challenges, and potential resolutions in today's complex health care landscape.
Sarah L. Weaver, RN
Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.
Strengthening Flu Defenses: How Pharmacies are Leading the Charge in Canada
Lessons can be learned from Canadian models of influenza vaccine management, including proactive patient conversations and optimal workflows.
National Academies Progress Report Shows Consequences of Underrepresentation in Clinical Research
The author suggest how to improve the representation of women, older adults, and minorities in clinical research that will require effort from a broad range of stakeholders.
Distinguishing Between Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome
Although small intestinal bacterial overgrowth (SIBO) and irritable bowel syndrome (IBS) share many of the same symptoms, SIBO affects the small intestine and IBS affects the large intestine.
Nipocalimab Data Submitted for FDA Approval in Generalized Myasthenia Gravis
The application includes data from the Vivacity-MG3 study, demonstrating that individuals who received the drug had superior outcomes compared with the standard of care alone.
Twice Yearly Inclisiran Demonstrates Meaningful LDL-C Lowering in Patients With ASCVD Risk
Pharmacists play an essential role in ensuring the medication is dispensed to patients with high atherosclerotic cardiovascular disease risk.
New Treatments Are Changing the Future of Alzheimer Disease
Despite questions and controversy around some clinical research, new understandings of the pathophysiology of the disease are pushing treatments forward.
Pharmacy Focus- Oncology Edition: Delayed Breast Cancer Screenings
Expert shares reasons why many women are behind on their annual breast cancer screenings, along with the latest cutting edge treatments in the breast cancer space.
Study: Researchers Find New Drug Target to Treat RSV
The findings further the understanding of respiratory virus immune evasion mechanisms and uncover how RSV-NS1 can target therapeutic intervention
Patients With Asthma Experience Changes in Airway Inflammation Following Electronic Cigarette Use
Using 1 nicotine-containing electronic cigarette was significantly correlated with an increase in residual volume and total lung capacity in patients with asthma.
Study: Children With First Dose of Measles Vaccine May Not Receive Both Globally
Pharmacists can help facilitate more organized efforts to improve measles vaccination uptake for children aged 5 and younger by identifying socio-demographic gaps within this population.
Efgartigimod Alfa Provides Much-Needed Treatment Options for Patients With Generalized Myasthenia Gravis
Pharmacists can provide extra resources for patients, including explanations of the therapy options for the patients, the course of therapy, and what patients can expect.
Rebekah Dant, PharmD, BCACP
Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.
Immunization Awareness Month Highlights the Role of Pharmacies
By sharpening our vaccine confidence skills and advocating for expanded immunization scopes of practice, we can help improve convenient vaccine access in the US.
Frequent Use of Surrogate Markers Could Create Uncertainty for Breakthrough-Designated Drugs
The use of surrogate markers was observed for breakthrough-designated indications that were approved through both traditional pathways and accelerated pathways.
Results of Extension Study Show Roflumilast Suitable for Children Aged 2 to 5 Years
In July 2024, the FDA approved the supplemental new drug application for roflumilast cream 0.15% for patients 6 years and older.
Treatment Approaches for Patients With Graft-Vs-Host Disease May Require Flexibility
Pharmacists support treatment adherence as well as monitor adverse effects, drug-drug interactions, and quality of life.
Experts: Vaccine Gap Program Can Address Variety of Health Care Gaps in Any Community
Jake Galdo and Annie Eisenbeis discuss their vaccine gap closure program and the ability to utilize the model beyond vaccines.
Effective Health Care Delivery Models, Partnerships Can Ease Burden of Diabetes
In an interview with Pharmacy Times, Jasmine Perry describes her idea of an effective health care delivery model and why research can have a huge impact at the policy level.
HHS Releases Campaign to Promote Vaccine Recommendations for RSV, COVID-19, and Flu
"Risk Less. Do More." plans to partner with national, state, and local organizations to provide resources to families and communities on how to protect themselves from RSV, influenza, and COVID-19.
FDA Grants Priory Review for Mirdametinib to Treat NF1-PN
Mirdametinib is an oral, allosteric small molecule MEK inhibitor to treat pediatric patients with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN).